Benign liver diseases also often cause damage to liver functions (liver cirrhosis, hepatitis, etc.), which may be the reason for the relatively small differences in levels of TBIL, PLT and ALB among HCC, CCA and benign liver diseases patient cohorts (Table 2). This evidence concerns the gene ALB and cholangiocarcinoma.